If the NNVC story is even close to being real, then this press release by the company this morning may present the most compelling buying opportunity we have seen yet in these shares:
"NanoViricides Says AviFluCide(TM)-I May be the Leading Drug Against H5N1 Avian Flu"
"The Company also announced that it has retained the services of the Gencarelli Group of Washington DC for business development purposes. The Gencarelli Group specializes in health and biotechnology business development in both public and private sectors."
"The company further announced that it has changed auditors as the company has grown quite rapidly and has now engaged the public auditing firm of Holtz Rubenstein Reminick LLP to perform the certified public audit. Holtz Rubenstein Reminick LLP is the "Fastest Growing Accounting Firm in America" (as recognized by both PAR, Sept. 2005, and Accounting Today, Apr. 2006) and one of the Top 25 Accounting Firms in New York (Crain's, Sept. 2005). It is a progressive regional accounting firm, providing a wide variety of accounting, tax and business advisory services to clients throughout the New York metropolitan area.
"The audit is expected to be completed in early July. We expect to file with the SEC in order to become a fully reporting company shortly thereafter."